Rizwana F. Sproule, VP Regulatory Affairs at Kite Pharma, Inc. (KITE), sold 19,034 shares at $45.07 ($858K) on 2016-02-17, disclosed to the SEC on 2016-02-19.
Open-market sale of $858k KITE by VP Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.07 | 9,467 | $427K | 49.7% |
| 2 | $45.07 | 9,467 | $427K | 49.7% |
| 3 | $46.01 | 100 | $5K | 0.5% |
| Total | $45.07 avg | 19,034 | $858K | 100% |
| Filing → |
| KITE | SELL | 2015-12-17 | $610K | — | Filing → |
| KITE | SELL | 2015-11-18 | $748K | — | Filing → |
| KITE | SELL | 2015-10-19 | $599K | — | Filing → |